Bio-activity prediction of drug candidate compounds targeting SARS-Cov-2 using machine learning approaches

bracu.type.groupResearch Publications
datacite.rightsOpen Access
dc.contributor.authorAshraf, Faisal Bin
dc.contributor.authorAkter, Sanjida
dc.contributor.authorMumu, Sumona Hoque
dc.contributor.authorIslam, Muhammad Usama
dc.contributor.authorUddin, Jasim
dc.contributor.departmentDepartment of Computer Science and Engineering
dc.date.accessioned2026-08-17T10:05:12Z
dc.date.available2026-08-17T10:05:12Z
dc.date.issued2023-09-01
dc.description.abstractThe SARS-CoV-2 3CLpro protein is one of the key therapeutic targets of interest for COVID-19 due to its critical role in viral replication, various high-quality protein crystal structures, and as a basis for computationally screening for compounds with improved inhibitory activity, bio-availability, and ADMETox properties. The ChEMBL and PubChem database contains experimental data from screening small molecules against SARS-CoV-2 3CLpro, which expands the opportunity to learn the pattern and design a computational model that can predict the potency of any drug compound against coronavirus before in-vitro and in-vivo testing. In this study, Utilizing several descriptors, we evaluated 27 machine learning classifiers. We also developed a neural network model that can correctly identify bioactive and inactive chemicals with 91% accuracy, on CheMBL data and 93% accuracy on combined data on both CheMBL and Pubchem. The F1-score for inactive and active compounds was 93% and 94%, respectively. SHAP (SHapley Additive exPlanations) on XGB classifier to find important fingerprints from the PaDEL descriptors for this task. The results indicated that the PaDEL descriptors were effective in predicting bioactivity, the proposed neural network design was efficient, and the Explanatory factor through SHAP correctly identified the important fingertips. In addition, we validated the effectiveness of our proposed model using a large dataset encompassing over 100,000 molecules. This research employed various molecular descriptors to discover the optimal one for this task. To evaluate the effectiveness of these possible medications against SARS-CoV-2, more in-vitro and in-vivo research is required. © 2023 Ashraf et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
dc.description.versionPublished
dc.format.extent19 pages
dc.identifier.citationAshraf FB, Akter S, Mumu SH, Islam MU, Uddin J (2023) Bio-activity prediction of drug candidate compounds targeting SARS-Cov-2 using machine learning approaches. PLoS ONE 18(9): e0288053. https://doi.org/10.1371/journal.pone.0288053
dc.identifier.doi10.1371/journal.pone.0288053
dc.identifier.issn19326203
dc.identifier.other2-s2.0-85169758709
dc.identifier.urihttps://hdl.handle.net/10361/29211
dc.language.isoen_US
dc.publisherPublic Library of Science
dc.relation.hasversion10.1371/journal.pone.0288053
dc.relation.ispartofPlos One
dc.relation.ispartofseriesPlos One
dc.relation.journalPLoS ONE
dc.relation.urihttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0288053
dc.rightstrue
dc.subjectBiological availability
dc.subjectCOVID-19
dc.subjectDrug compounding
dc.subjectHumans
dc.subjectMachine learning
dc.subjectSARS-CoV-2
dc.subject.lcshStructure-activity relationships (Biochemistry).
dc.subject.lcshCOVID-19 (Disease)--Chemotherapy.
dc.subject.lcshMachine learning.
dc.subject.lcshCOVID-19 (Disease)--Epidemiology--Simulation methods.
dc.subject.lcshCOVID-19 (Disease)--Diagnosis--Simulation methods.
dc.subject.lcshArtificial intelligence--Medical applications.
dc.titleBio-activity prediction of drug candidate compounds targeting SARS-Cov-2 using machine learning approaches
dc.typeArticle
oaire.citation.issue9 September
oaire.citation.volume18
person.affiliation.nameBRAC University
person.affiliation.nameUniversity of California, Riverside
person.affiliation.nameUniversity of Louisiana at Lafayette
person.affiliation.nameSchool of Computing & Informatics
person.affiliation.nameCardiff Metropolitan University
person.identifier.scopus-author-id57194202985
person.identifier.scopus-author-id58580793300
person.identifier.scopus-author-id58562014800
person.identifier.scopus-author-id57225862379
person.identifier.scopus-author-id57200878233

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Bio-activity prediction of drug candidate compounds targeting SARS-Cov-2 using machine learning approaches.pdf
Size:
1.52 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: